# A Safety and Tolerability Study of FCN-207 in Healthy Volunteers

> **NCT04622124** · PHASE1 · COMPLETED · sponsor: **Fochon Pharmaceuticals, Ltd.** · enrollment: 132 (actual)

## Conditions studied

- Hyperuricemia

## Interventions

- **DRUG:** Placebo
- **DIETARY_SUPPLEMENT:** fasted vs. high-fat meal
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04622124
- **Lead sponsor:** Fochon Pharmaceuticals, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-11
- **Primary completion:** 2021-12-21
- **Final completion:** 2022-06-07
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2024-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04622124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04622124, "A Safety and Tolerability Study of FCN-207 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04622124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*